Federated Hermes’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,956,488
| Closed | -$42.3M | – | 2312 |
|
|
2022
Q4 | $42.3M | Sell |
1,956,488
-301,636
| -13% | -$6.37M | 0.12% | 221 |
|
|
2022
Q3 | $43.7M | Buy |
2,258,124
+3,000
| +0.1% | +$62K | 0.13% | 204 |
|
|
2022
Q2 | $44.8M | Sell |
2,255,124
-103,500
| -4% | -$2.73M | 0.12% | 217 |
|
|
2022
Q1 | $70.4M | Hold |
2,358,624
| – | – | 0.16% | 173 |
|
|
2021
Q4 | $54.9M | Sell |
2,358,624
-1,900
| -0.1% | -$50.5K | 0.1% | 256 |
|
|
2021
Q3 | $73.6M | Sell |
2,360,524
-534
| -0% | -$16.5K | 0.14% | 204 |
|
|
2021
Q2 | $83.1M | Hold |
2,361,058
| – | – | 0.15% | 180 |
|
|
2021
Q1 | $83.2M | Sell |
2,361,058
-85,942
| -4% | -$3.17M | 0.16% | 168 |
|
|
2020
Q4 | $91.8M | Buy |
2,447,000
+32,100
| +1% | +$1.17M | 0.19% | 141 |
|
|
2020
Q3 | $80.6M | Buy |
2,414,900
+501,710
| +26% | +$14.6M | 0.19% | 130 |
|
|
2020
Q2 | $50.7M | Hold |
1,913,190
| – | – | 0.13% | 186 |
|
|
2020
Q1 | $31.3M | Buy |
1,913,190
+476,190
| +33% | +$10.5M | 0.09% | 242 |
|
|
2019
Q4 | $36.5M | Hold |
1,437,000
| – | – | 0.08% | 271 |
|
|
2019
Q3 | $28.7M | Hold |
1,437,000
| – | – | 0.07% | 283 |
|
|
2019
Q2 | $46.3M | Buy |
1,437,000
+717,405
| +100% | +$24M | 0.11% | 203 |
|
|
2019
Q1 | $23.2M | Buy |
719,595
+133,449
| +23% | +$3.59M | 0.06% | 312 |
|
|
2018
Q4 | $14.4M | Sell |
586,146
-61
| -0% | -$1.61K | 0.04% | 383 |
|
|
2018
Q3 | $19.3M | Buy |
586,207
+61
| +0% | +$2K | 0.05% | 362 |
|
|
2018
Q2 | $20.8M | Buy |
586,146
+276,221
| +89% | +$8.95M | 0.06% | 246 |
|
|
2018
Q1 | $10.1M | Buy |
+309,925
| New | +$10.4M | 0.03% | 422 |
|
Other funds holding ALBO
Federated Hermes's ALBO Position: Q1 2023 in Review
Federated Hermes sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,956,488 shares — an estimated $42.3M sold.
Federated Hermes first reported a position in ALBO in Q1 2018 and held it in 20 quarters. The position peaked at $91.8M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Federated Hermes reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Federated Hermes sold 1,956,488 Albireo Pharma Inc shares in Q1 2023, an estimated $42.3M.
- Federated Hermes first reported a position in Albireo Pharma Inc in Q1 2018 and held it in 20 quarters.
- Federated Hermes's Albireo Pharma Inc position peaked at $91.8M in Q4 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.